tirzepatide clinical trial enrollment Tirzepatide: A Systematic Update Summary of clinical trials that

Clinical Trial Registration ClinicalTrials.gov: NCT04235959

who want to do a more comprehensive review of these medications and potential ocular side effects, Katz added

And stick to your rotation schedule even when your routine is disrupted

You should see a doctor if you experience any new or worsening vision changes, such as: blurred vision dark spots flashes of light sudden vision loss For people without diabetes or without existing eye disease, eye-related side effects are considered very unlikely

In the head-to-head ACHIEVE-3 trial , orforglipron outperformed oral semaglutide for both A1C reduction and weight loss outcomes